| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mallinckrodt plc | EVP & CHRO | Ordinary Shares | 782 | $67,643 | $86.50 | 31 Jul 2025 | Direct |
| Keenova Therapeutics plc | EVP & CHRO | Restricted Stock Units | 48,240 | 25 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465926020866-basso-tracy-2026-02-25 | Keenova Therapeutics plc | 25 Feb 2026 | 1 | $0 | 4 | EVP & CHRO | 26 Feb 2026, 21:09 |
| /report/000110465925073782-basso-tracy-2025-07-31 | Mallinckrodt plc | 31 Jul 2025 | 2 | $0 | 4 | EVP & CHRO | 04 Aug 2025, 20:47 |
| /report/000110465925073771-basso-tracy-2025-07-31 | Mallinckrodt plc | 31 Jul 2025 | 0 | $0 | 3 | EVP & CHRO | 04 Aug 2025, 20:38 |